DrugPatentWatch Database Preview

BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Bacteriostatic Sodium Chloride 0.9% In Plastic Container patents expire, and what generic alternatives are available?

Bacteriostatic Sodium Chloride 0.9% In Plastic Container is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, and Hospira. and is included in three NDAs.

The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.

Summary for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	3
NDAs:	3
Suppliers / Packagers:	4
Bulk Api Vendors:	142
Clinical Trials:	19
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed

Pharmacology for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Drug Class	Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

US Patents and Regulatory Information for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abraxis Pharm	BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	088909-001	Feb 7, 1985		DISCN	No	No
Fresenius Kabi Usa	BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	088911-001	Feb 7, 1985	AP	RX	No	No
Hospira	BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	018800-001	Oct 29, 1982	AP	RX	Yes	Yes